Killing Is Not Enough: How Apoptosis Hijacks Tumor-Associated Macrophages to Promote Cancer Progression
Related Experiment Video
Updated: Mar 15, 2026

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
Andreas Weigert1, Javier Mora1, Divya Sekar1
1Faculty of Medicine, Institute of Biochemistry I, Goethe-University Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.
Abstract:
Macrophages are a group of heterogeneous cells of the innate immune system that are crucial to the initiation, progression, and resolution of inflammation. Moreover, they control tissue homeostasis in healthy tissue and command a broad sensory arsenal to detect disturbances in tissue integrity. Macrophages possess a remarkable functional plasticity to respond to irregularities and to initiate programs that allow overcoming them in order to return back to normal. Thus, macrophages kill malignant or transformed cells, rearrange extracellular matrix, take up and recycle cellular as well as molecular debris, initiate cellular growth cascades, and favor directed migration of cells. As an example, apoptotic death of bystander cells is sensed by macrophages, initiating functional responses that support all hallmarks of cancer. In this chapter, we describe how tumor cell apoptosis hijacks tumor-associated macrophages to promote tumor growth. We propose that tumor therapy should not only kill malignant cells but also target the interaction of the host with apoptotic cancer cells, as this might be efficient to limit the protumor action of apoptotic cells and boost the antitumor potential of macrophages. Leaving the apoptotic cell/macrophage interaction untouched might also limit the benefit of conventional tumor cell apoptosis-focused therapy since surviving tumor cells might receive overwhelming support by the wound healing response that apoptotic tumor cells will trigger in local macrophages, thereby enhancing tumor recurrence.
Insights
Tumor cell apoptosis can promote cancer growth by hijacking tumor-associated macrophages. Targeting this interaction is crucial for effective cancer therapy to limit pro-tumor effects and enhance anti-tumor immunity.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Macrophages are key innate immune cells regulating inflammation and tissue homeostasis.
- These cells exhibit functional plasticity, responding to tissue damage and initiating repair processes.
- Tumor-associated macrophages (TAMs) play a complex role in cancer progression.
Purpose of the Study:
- To elucidate how tumor cell apoptosis influences tumor-associated macrophages (TAMs).
- To propose therapeutic strategies targeting the interaction between apoptotic cancer cells and TAMs.
- To understand the implications of this interaction for cancer therapy efficacy and recurrence.
Main Methods:
- Review of existing literature on macrophage biology and cancer immunology.
- Analysis of mechanisms by which apoptotic cells modulate macrophage function.
- Conceptual framework for therapeutic targeting of the apoptotic cell-macrophage axis in cancer.
Main Results:
- Tumor cell apoptosis can be co-opted by cancer to promote tumor growth via TAMs.
- Apoptotic cancer cells can trigger TAMs to support tumor progression and wound healing responses.
- This interaction may counteract the benefits of conventional apoptosis-focused cancer therapies.
Conclusions:
- Targeting the interaction between apoptotic tumor cells and TAMs is a promising therapeutic avenue.
- Such strategies could limit pro-tumorigenic TAM functions and enhance anti-tumor immunity.
- Interfering with this axis may improve outcomes for conventional cancer treatments and reduce tumor recurrence.
Related Concept Videos
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

